comparemela.com
Home
Live Updates
Phillip Chan - Breaking News
Pages:
13
14
15
16
17
18
19
Latest Breaking News On - Phillip chan - Page 12 : comparemela.com
CytoSorbents to Present at Two Upcoming Investor Conferences
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
United states
Eric kim
Phillip chan
Kathleen bloch
Us department of health
Human services
Material command
National institutes of health
Prnewswire cytosorbents corporation
Us air
Corporate communications
European union
Us army
Blood institute
Cytosorbents corporation
National heart
Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2022 Results - Earnings Call Transcript
Cytosorbents Corporation (NASDAQ:NASDAQ:CTSO) Q1 2022 Earnings Conference Call May 03, 2022 04:30 PM ET Company Participants Terri Anne Powers - Vice President, Investor Relations &.
United kingdom
City of
United states
New jersey
Priya sachdeva
Jiny kim
Cytosorbents europe
Asklepios kliniken gmb
Shaun whittemore
Kathy bloch
Makis deliargyris
Christian steiner
Chris cramer
Phillip chan
Justin walsh
Christopher cramer
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
Press release content from PR Newswire. The AP news staff was not involved in its creation.
United states
United kingdom
State of new jersey
New jersey
Bruxelles capitale
City of
Monmouth junction
Jiny kim
Eric kim
Phillip chan
Buildout of the company
Euroelso congress
Material command
European union
Us army
Blood institute
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
Q1 2022 total revenue was $8.7 million, including product sales of $7.9 million. Core non-COVID-19 product sales were an estimated $7.6 million, .
United states
United kingdom
State of new jersey
New jersey
Bruxelles capitale
City of
Monmouth junction
Jiny kim
Eric kim
Phillip chan
Buildout of the company
Euroelso congress
Material command
European union
Us army
Blood institute
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
United states
United kingdom
State of new jersey
New jersey
Bruxelles capitale
City of
Jiny kim
Eric kim
Phillip chan
Buildout of the company
Euroelso congress
Material command
European union
Us army
Blood institute
National heart
vimarsana © 2020. All Rights Reserved.